28.09.2018 09:47:31

DGAP-NVR: Elanix Biotechnologies AG: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

DGAP Total Voting Rights Announcement: Elanix Biotechnologies AG / Total Voting Rights Announcement
Elanix Biotechnologies AG: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

28.09.2018 / 09:47
Total Voting Rights Announcement transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Publication of total number of voting rights

1. Details of issuer
Elanix Biotechnologies AG
Kurfürstendamm 32
10719 Berlin
Germany

2. Type of capital measure
  Type of capital measure Date of status / date of effect
  Conditional capital increase (Sec. 41 para. 2 WpHG)
X Other capital measure (Sec. 41 para. 1 WpHG) 27 Sep 2018

3. New total number of voting rights:
8.080.902



28.09.2018 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: Elanix Biotechnologies AG
Kurfürstendamm 32
10719 Berlin
Germany
Internet: www.elanixbiotechnologies.com

 
End of News DGAP News Service

728503  28.09.2018 

fncls.ssp?fn=show_t_gif&application_id=728503&application_name=news&site_id=smarthouse

Nachrichten zu Elanix Biotechnologies AGmehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Elanix Biotechnologies AGmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!